GlaxoSmithKline: Diabetes Mellitus, Type 2 trials
The registry lists 136 Diabetes Mellitus, Type 2 studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 46 have results posted.
Phase 1 51Phase 2 23Phase 3 29Phase 4 23No phase 11(a study in two phases counts in both)
Studies
Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy VolunteersCompletedNCT00501930Phase 1
- A Single Dose Of GSK189075 Taken By Mouth Containing Small Amounts Of Radioactivity Studied In Healthy Male VolunteersCompletedNCT00501683Phase 1
- A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney FunctionCompletedNCT00501462Phase 1
- A Study of the Effects of Ketoconazole Taken Orally Has on the PK Profiles of a Dose of GSK189075 in Healthy VolunteersCompletedNCT00501397Phase 1
- Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of MetforminCompletedNCT00501020Phase 4
- Rosiglitazone on Microalbuminuria in Type 2 DiabeticsCompletedNCT00500955Phase 3
- Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes SubjectsCompletedNCT00499707Phase 3
- Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight SubjectsCompletedNCT00495014Phase 1
- Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active DrugsCompletedNCT00494767Phase 1
- A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes MellitusTerminatedNCT00437164Phase 2
- A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight SubjectsCompletedNCT00404963Phase 1
- Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy VolunteersCompletedNCT00394030Phase 1
- Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)WithdrawnNCT00387972Phase 2/3
- Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 DiabetesCompletedNCT00376038Phase 1
- GW823093C For The Treatment Of Type 2 Diabetes MellitusTerminatedNCT00370942Phase 2
- AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 DiabetesCompletedNCT00359112Phase 3
- In-patient Study With GSK716155 In Patients With Type 2 Diabetes MellitusCompletedNCT00354536Phase 2
- A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus PatientsCompletedNCT00349427Phase 3
- AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide AloneCompletedNCT00333723Phase 4
- Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On InsulinCompletedNCT00329225Phase 4
- Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In KoreaCompletedNCT00328965Phase 4
- Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.CompletedNCT00306696Phase 4
- Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 DiabetesCompletedNCT00306644Phase 4
- BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-CompletedNCT00297063Phase 3
- GSK189075, GW869682 Or Placebo In Type 2 Diabetic PatientsCompletedNCT00291356Phase 2
- Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/GlibenclamideCompletedNCT00279045Phase 3
- Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or InsulinCompletedNCT00269061Phase 1
- In-patient Study in Patients With Type 2 Diabetes MellitusCompletedNCT00259896Phase 1
- AVANDAMET Versus Metformin For Type 2 Diabetes MellitusCompletedNCT00241605Phase 4
- Rosiglitazone And Plaque Study for Type 2 Diabetes MellitusCompletedNCT00231387Phase 3
- Study In People With Type 2 DiabetesCompletedNCT00196989Phase 2
- Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.CompletedNCT00069836Phase 3
- A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II DiabeticsCompletedNCT00067951Phase 3
- Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And HypertensionCompletedNCT00060931Phase 4
- Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And HypertensionCompletedNCT00060918Phase 4
- Efficacy and Safety In Poorly Controlled Type 2 DiabeticsCompletedNCT00044460Phase 4